N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy
摘要:
A series of N-pyridyl benzamide KCNQ2/Q3 potassium channel openers were identified and found to be active in animal models of epilepsy and pain. The best compound 12 [ICA-027243, N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide] has an EC(50) of 0.38 mu M and is selective for KCNQ2/Q3 channels. This compound was active in several rodent models of epilepsy and pain but upon repeated dosing had a number of unacceptable toxicities that prevented further development. On the basis of the structure activity relationships developed around 12, a second compound, 51, [N-(2-chloro-pyrimidin-5-yl)-3,4-difluoro-benzamide, ICA-069673], was prepared and advanced into a phase 1 clinical study. Herein, we describe the structure activity relationships that led to the identification of compound 12 and to the corresponding pyrimidine 51.
Pyrimidines as novel openers of potassium ion channels
申请人:Icagen, Inc.
公开号:US20030181465A1
公开(公告)日:2003-09-25
The present invention provides a genus of pyrimidine amides that are useful as openers of potassium ion channels. The compounds of the invention are of use in both therapeutic and diagnostic methods.
PYRIMIDINES AS NOVEL OPENERS OF POTASSIUM ION CHANNELS
申请人:Icagen, Inc.
公开号:EP1483259A1
公开(公告)日:2004-12-08
US7205307B2
申请人:——
公开号:US7205307B2
公开(公告)日:2007-04-17
[EN] PYRIMIDINES AS NOVEL OPENERS OF POTASSIUM ION CHANNELS<br/>[FR] PYRIMIDINES UTILISEES COMME NOUVEAUX AGENTS D'OUVERTURE DES CANAUX IONIQUES DE POTASSIUM
申请人:ICAGEN INC
公开号:WO2003068767A1
公开(公告)日:2003-08-21
The present invention provides a genus of pyrimidine amides that are useful as openers of potassium ion channels. The compounds of the invention are of use in both therapeutic and diagnostic methods.